Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 176-200 of 1083 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
controlling the symptoms of patients with COVID-19
Design:
This study is a single-center, prospective (...) , fever) confirm COVID-19;
Confirmed diagnosis of COVID-19, with either lung CT-Scan result, which is typical for COVID-19 pulmonary involvement,or RT-PCR confirmation;
Less than 7 days have passed since the
the symptoms of patients with COVID-19
Design:
This study is a single-center, prospective, randomized (...) ) confirm COVID-19. Confirmed diagnosis of COVID-19, with either lung CT-Scan result, which is typical for COVID-19 pulmonary involvement,or RT-PCR confirmation. Less than 7 days have passed since the onset of
hydroxychloroquine + azithromycin in hospitalized patients with covid-19 in the intensive care unit
Design:
Clinical (...) /Inclusion and exclusion criteria:
Inpatients with COVID-19 in ICU of Shahid Modarres Hospital
- Inclusion criteria:
Diagnosis of COVID-19 based on either ground glass appearance in chest CT scan or positive PCR
patients with COVID-19
Design:
A phase 3, Placebo-controlled, Paralleled, double-blind, randomized (...) population is 84 patients with COVID-19 (42 patients in control group and 42 in study group).
Participants (...) ) test for COVID-19 or/and lung involvement in imaging, age ≥18 years, primary clinical symptoms, non
patients with COVID-19
Design:
This study is a single-center, prospective, randomized, open-labeled (...)COVID-19. Confirmed diagnosis of COVID-19, with either lung CT-Scan result, which is typical for COVID-19 pulmonary involvement,or RT-PCR confirmation. Less than 7 days have passed since the onset of
on clinical and laboratory findings of COVID-19 patients with standard treatment: a randomized (...) of random numbers for 60 admitted patients of confirmed COVID-19 in Masih Daneshvari Hospital from (...) conduct:
This study will be performed in Masih Danesvari hospital,Tehran, Iran. 60 covid-19 confirmed
test.
Exclusion criteria: previous COVID-19 treatment, allergy and asthma, hypertension, diabetes (...) prescribed medications to treat COVID-19, they will be received 200 cc of medical beer every 4 hours for 5 (...) the Ministry of Health to treat COVID-19.
Main outcome variables:
The length of hospital stay, fever
symptoms of patients with COVID-19
Design:
This study is a single-center, prospective, randomized, open (...)COVID-19. Confirmed diagnosis of COVID-19, with either lung CT-Scan result, which is typical for COVID-19 pulmonary involvement,or RT-PCR confirmation. Less than 7 days have passed since the onset of
the symptoms of patients with COVID-19
Design:
This study is a single-center, prospective, randomized (...) ) confirm COVID-19. Confirmed diagnosis of COVID-19, with either lung CT-Scan result, which is typical for COVID-19 pulmonary involvement,or RT-PCR confirmation. Less than 7 days have passed since the onset of
COVID- 19
Design:
Clinical trial with control group with parallel, Open labeled, Randomised
Settings (...) Birjand University of Medical Sciences on approved COVID-19 patients. Patients are treated in two groups (...) PCR test for COVID-19 disease or patients who show evidence of lung involvement on CT scans.
The
Study aim:
Determining the effect of plasma administration of COVID-19 survivors on one-month mortality of patients with acute respiratory distress syndrome during COVID-19 disease
Design:
All hospitalized patients with acute COVID-19 respiratory distress syndrome who are eligible are placed in the
pulegium and Urtica) in controlling symptoms in patients with COVID-19
Design:
This study is a single (...) cough, shortness of breath, fever) confirm COVID-19.
Confirmed diagnosis of COVID-19, with either lung CT-Scan result, which is typical for COVID-19 pulmonary involvement,or RT-PCR confirmation.
Less than
Study aim:
Comparison of the Effectiveness of Tenofovir antiviral drug beside routine drug regime (standard of care) in COVID-19 patients
Design:
Clinical trial with control group, parallel group trial, open lable, phase 2 on 60 patients. Replacement randomization was used.
Settings and conduct:
In both
Coronavirus (COVID-19)-induced pneumonia will be studied.
Design:
A clinical trial with a control group, with (...) regimen for COVID-19. Control group: patients in the control group will be prescribed the standard regimen for COVID-19.
Main outcome variables:
The change of pneumonia severity on CT scan images
clinical signs of suspected viral infection, Covid-19 tests will be carried out based on the national (...) group and one placebo group.
Main outcome variables:
Covid-19 virus infection (...) Study aim:
Comparison of the effect of hydroxychloroquine with placebo on prevention of virus Covid
suspected of COVID-19
Determining the Effect of Persian medicine products on Respiratory Rate in Patients With or Suspected of COVID-19
The effect of Persian medicine products on CRP levels of patients with or suspected of COVID-19
The effect of Persian medicine products on lymphocyte levels in patients with or
Study aim:
1. comparing Recigen and placebo in the reduction of dyspnea in covid19 patients
2. comparing Recigen and placebo in the reduction of cough in covid19 patients
3. comparing Recigen and placebo in the reduction of hypoxia in covid19 patients
4. comparing Recigen and placebo in the reduction
Study aim:
Determining the effect of educational intervention based on social support theory in reducing stress caused by COVID-19 disease epidemic in people with diabetes
Design:
Samples are 212 people (...) ; suffering from COVID-19
Intervention groups:
In this study, there will be two groups of intervention and
Study aim:
Determining the effectiveness of "SALIRAVIRA" as a natural product containing of Licorice, Coneflower, Ginseng, Hyssop, Rhubarb and Rosemary extracts to coronavirus load in COVID-19(...)
Participants/Inclusion and exclusion criteria:
Inclusion criteria: COVID-19 patient confirmed by positive PCR
pneumonia requiring non-invasive ventilation induced by Covid19
Design:
A clinical trial, with a control (...) conduct:
location: Ghaem hospital of Mashhad.
All patients will receive standard Covid19 treatment (...) two groups.
Participants/Inclusion and exclusion criteria:
Patients with severe covid-19, who
hospitalized covid-19 patients.
Design:
double blind randomized clinical trail. with control group, phase 3 (...) study.
Participants/Inclusion and exclusion criteria:
inclusion criteria:
consent
age 18-75 years
covid-19 patients
hospitalized patients
exclusion criteria:
consent not given
not within the 18-75 years
old
Inclusion criteria: Diagnosis of COVID19 Patients that do not need to be admitted in hospital (...) Study aim:
Evaluating the safety of sofosbuvir 800mg /Daclatasvir 120 mg in outpatient with COVID19
Design:
Study group: one arm open-label study with only one intervention group consists of 50
to both lungs on moderate to severe cases of COVID-19 pneumonia
Settings and conduct:
Patients are (...) monitored for 28 days post treatment.
Participants/Inclusion and exclusion criteria:
Confirmed COVID-19(...) criteria receive standard national protocol of COVID-19 treatment plus low dose radiotherapy to both lungs
Study aim:
To evaluate the safety and efficacy of losartan in COVID-19
Design:
One-hundred patients with COVID-19 after taking informed consent including 50 patients in the case group and 50 (...) (COVID-19). Losartan (25mg/BID) in one group and amlodipine (5mg/daily) in another group will be
Study aim:
Evaluation of effectiveness of Intravenous vit c in Patients with COVID-19
Design:
Two arm parallel group randomized trial with sample size 110 patients. In case group 55 patients treat (...) probable case of covid-19
At least 18 years old
Exclusion Criteria:
The Patient with chronic renal diseases